Respiratory

Latest News

biosimilar business deal | Image credit: Mongkolchon - stock.adobe.com
Latest Biosimilar Deals Signal Growth Across Immunology, Oncology Markets

April 14th 2025

During Q1 2025, pharmaceutical companies accelerated biosimilar expansion through strategic acquisitions and partnerships in hopes of boosting patient access to lower-cost treatments in immunology and oncology.

FDA approved omalizumab biosimilar | Image credit: Rafael Henrique - stock.adobe.com
FDA Approves First Omalizumab Biosimilar

March 7th 2025

FDA approved Avtozma | Image credit: wladimir1804 - stock.adobe.com
FDA Approves Celltrion's Avtozma as Third Tocilizumab Biosimilar

January 31st 2025

kid with asthma | Image credit: Pixel-Shot - stock.adobe.com
Health Canada Approves First Omalizumab Biosimilar

December 16th 2024

lung and lung cancer | Image credit: mi_viri - stock.adobe.com
Retrospective Study Shows Bevacizumab Biosimilar Efficacy in NSCLC

November 27th 2024

More News

© 2025 MJH Life Sciences

All rights reserved.